Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
SMARTSCORE: 2.8/5
Incyte Corp (INCY US)
Watchlist
71
Analysis
Health Care
•
United States
Incyte Corp is a biopharmaceutical company. The Company discovers, develops and commercializes proprietary small molecule drugs, primarily used in oncology.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Incyte Corp
•
12 May 2025 07:00
Incyte Corporation: Here Are The 5 Major Factors Propelling Our ‘Outperform’ Rating!
Incyte's first-quarter 2025 earnings report presents a mixed bag of results and outlooks, offering valuable insights for investors contemplating...
Baptista Research
Follow
192 Views
Share
bullish
•
Incyte Corp
•
19 Feb 2025 06:01
Incyte: Can Opzelura Offset Jakafi’s $3.7B Patent Cliff by 2028?
Incyte Corporation's recent financial and corporate update for the fourth quarter and full year 2024 showcases a year of significant growth and...
Baptista Research
Follow
410 Views
Share
bullish
•
Incyte Corp
•
05 Dec 2024 18:00
The Takeover Buzz Around Incyte: What Makes It Irresistible to Big Pharma?
Incyte Pharmaceuticals has been the center of takeover speculation recently, with its stock rallying amid whispers of a potential...
Baptista Research
Follow
923 Views
Share
bullish
•
Incyte Corp
•
06 Nov 2024 08:00
Incyte Corporation: Will Their Focus on Oncological Innovations Pay Off? - Major Drivers
Incyte exhibited a robust performance in its third quarter of 2024, marking a notable year of growth and advancement in its drug portfolio. Total...
Baptista Research
Follow
254 Views
Share
bullish
•
Incyte Corp
•
08 Aug 2024 07:00
Incyte Corporation: A Story Of Robust Pipeline Development and Strategic Acquisitions! - Major Drivers
Incyte Corporation reported its financial performance for the second quarter of 2024 with several notable highlights and strategic decisions that...
Baptista Research
Follow
206 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.10
x